Objectives The metabolic syndrome ( MS) is associated with left ventricular hypertrophy (LVH). Previous evidence has shown that LVH is favoured by low levels of atrial natriuretic peptide (ANP), independently from blood pressure ( BP), in hypertension. Although levels of natriuretic peptides are known to be lower in obesity, plasma ANP levels have not yet been assessed in MS. We aimed to assess the ANP levels and their relationship with left ventricular mass ( LVM) in patients affected by MS. Methods One hundred and twenty-eight essential hypertensive patients were included in the study: 51 with MS and 77 without MS. Clinical, echocardiographical and biochemical parameters, and levels of both N-terminal (NT)-proANP and alphaANP were assessed. Results Hypertensive patients affected by MS had higher LVM and increased frequency of LVH. NT-proANP levels were significantly lower in MS, independent of waist circumference ( WC). Log( NT-proANP) levels were significantly inversely related to left ventricular mass index (LVMI) (beta=-0.360, P < 0.001) and LVM/height(2.7) (beta=-0.370, P < 0.001) in the whole hypertensive population by multiple linear regression analysis. The relationship of log( NT-proANP) with LVM was more enhanced in patients with MS. Conclusions The present study demonstrates that levels of NT-proANP are significantly reduced in hypertensive patients affected by MS, and they are significantly inversely related to the increased LVM observed in these patients. Our findings, while supporting previous experimental and clinical evidence of the antihypertrophic role of ANP in hypertension, may help to identify one of the possible mechanisms directly underlying LVH in MS.

Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass / Rubattu, Speranza Donatella; Sciarretta, Sebastiano; Ciavarella, GIUSEPPINO MASSIMO; Vanessa, Venturelli; Paola De, Paolis; Tocci, Giuliano; DE BIASE, Luciano; Ferrucci, Andrea; Volpe, Massimo. - In: JOURNAL OF HYPERTENSION. - ISSN 0263-6352. - 25:4(2007), pp. 833-839. [10.1097/hjh.0b013e32803cae3c]

Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass

RUBATTU, Speranza Donatella;SCIARRETTA, SEBASTIANO;CIAVARELLA, GIUSEPPINO MASSIMO;TOCCI, GIULIANO;DE BIASE, Luciano;FERRUCCI, Andrea;VOLPE, Massimo
2007

Abstract

Objectives The metabolic syndrome ( MS) is associated with left ventricular hypertrophy (LVH). Previous evidence has shown that LVH is favoured by low levels of atrial natriuretic peptide (ANP), independently from blood pressure ( BP), in hypertension. Although levels of natriuretic peptides are known to be lower in obesity, plasma ANP levels have not yet been assessed in MS. We aimed to assess the ANP levels and their relationship with left ventricular mass ( LVM) in patients affected by MS. Methods One hundred and twenty-eight essential hypertensive patients were included in the study: 51 with MS and 77 without MS. Clinical, echocardiographical and biochemical parameters, and levels of both N-terminal (NT)-proANP and alphaANP were assessed. Results Hypertensive patients affected by MS had higher LVM and increased frequency of LVH. NT-proANP levels were significantly lower in MS, independent of waist circumference ( WC). Log( NT-proANP) levels were significantly inversely related to left ventricular mass index (LVMI) (beta=-0.360, P < 0.001) and LVM/height(2.7) (beta=-0.370, P < 0.001) in the whole hypertensive population by multiple linear regression analysis. The relationship of log( NT-proANP) with LVM was more enhanced in patients with MS. Conclusions The present study demonstrates that levels of NT-proANP are significantly reduced in hypertensive patients affected by MS, and they are significantly inversely related to the increased LVM observed in these patients. Our findings, while supporting previous experimental and clinical evidence of the antihypertrophic role of ANP in hypertension, may help to identify one of the possible mechanisms directly underlying LVH in MS.
2007
essential hypertension; left ventricular mass; metabolic syndrome; natriuretic peptides
01 Pubblicazione su rivista::01a Articolo in rivista
Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass / Rubattu, Speranza Donatella; Sciarretta, Sebastiano; Ciavarella, GIUSEPPINO MASSIMO; Vanessa, Venturelli; Paola De, Paolis; Tocci, Giuliano; DE BIASE, Luciano; Ferrucci, Andrea; Volpe, Massimo. - In: JOURNAL OF HYPERTENSION. - ISSN 0263-6352. - 25:4(2007), pp. 833-839. [10.1097/hjh.0b013e32803cae3c]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/232960
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 35
social impact